Validation of the Systemic Lupus International Collaborating Clinics classification criteria in a cohort of patients with full house glomerular deposits

Kidney International

Volumn 93, Issue 1, 2018, Pages 214-220

  Rijnink, Emilie C ^a   Teng, Y K Onno ^a   Kraaij, Tineke ^a   Dekkers, Olaf M ^a   Bruijn, Jan A ^a   Bajema, Ingeborg M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

lupus; renal pathology; systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD; BIOPSY; CLASSIFICATION; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULUS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION STUDY; YOUNG ADULT;

ADULT; ANTIBODIES, ANTINUCLEAR; BIOPSY; DECISION SUPPORT TECHNIQUES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 85029740012     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2017.07.017     Document Type: Article

References (34)

1. Bertsias, G.K., Pamfil, C., Fanouriakis, A., Boumpas, D.T., Diagnostic criteria for systemic lupus erythematosus: has the time come?. Nat Rev Rheumatol 9 (2013), 687–694.
2. Petri, M., Magder, L., Classification criteria for systemic lupus erythematosus: a review. Lupus 13 (2004), 829–837.
3. Huerta, A., Bomback, A.S., Liakopoulos, V., et al. Renal-limited “lupus-like” nephritis. Nephrol Dial Transplant 27 (2012), 2337–2342.
4. Wen, Y.K., Chen, M.L., Clinicopathological study of originally non-lupus “full-house” nephropathy. Ren Fail 32 (2010), 1025–1030.
5. Rijnink, E.C., Teng, Y.K., Kraaij, T., et al. Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome. Nephrol Dial Transplant 32 (2017), 654–662.
6. Jones, E., Magil, A., Nonsystemic mesangiopathic glomerulonephritis with “full house” immunofluorescence: pathological and clinical observation in five patients. Am J Clin Pathol 78 (1982), 29–34.
7. Lee, L.C., Lam, K.K., Lee, C.T., et al. “Full house” proliferative glomerulonephritis: an unreported presentation of subacute infective endocarditis. J Nephrol 20 (2007), 745–749.
8. Miura, M., Tomino, Y., Nomoto, Y., et al. IgA nephropathy with “Full House” immunofluorescence. Am J Clin Pathol, 79, 1983, 273.
9. Sharman, A., Furness, P., Feehally, J., Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 19 (2004), 1420–1426.
10. Smet, A.D., Kuypers, D., Evenepoel, P., et al. “Full house” positive immunohistochemical membranoproliferative glomerulonephritis in a patient with portosystemic shunt. Nephrol Dial Transplant 16 (2001), 2258–2262.
11. Petri, M., Orbai, A.M., Alarcon, G.S., et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64 (2012), 2677–2686.
12. Tan, E.M., Cohen, A.S., Fries, J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982), 1271–1277.
13. Hochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 40, 1997, 1725.
14. Weening, J.J., D'Agati, V.D., Schwartz, M.M., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65 (2004), 521–530.
15. Hanly, J.G., O'Keeffe, A.G., Su, L., et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 55 (2016), 252–262.
16. Agmon-Levin, N., Mosca, M., Petri, M., Shoenfeld, Y., Systemic lupus erythematosus one disease or many?. Autoimmun Rev 11 (2012), 593–595.
17. Wandstrat, A.E., Carr-Johnson, F., Branch, V., et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 27 (2006), 153–160.
18. Madrid, F.F., Maroun, M.C., Serologic laboratory findings in malignancy. Rheum Dis Clin North Am 37 (2011), 507–525.
19. Adu, D., Williams, D.G., Taube, D., et al. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q J Med 52 (1983), 471–487.
20. Gianviti, A., Barsotti, P., Barbera, V., et al. Delayed onset of systemic lupus erythematosus in patients with “full-house” nephropathy. Pediatr Nephrol 13 (1999), 683–687.
21. Cairns, S.A., Acheson, E.J., Corbett, C.L., et al. The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis. Postgrad Med J 55 (1979), 723–727.
22. Ruggiero, B., Vivarelli, M., Gianviti, A., et al. Outcome of childhood-onset full-house nephropathy. Nephrol Dial Transplant 32 (2017), 1194–1204.
23. Lai, F.M., To, K.F., Wang, A.Y., et al. Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities. Mod Pathol 13 (2000), 166–172.
24. Chen, Y.C., Kuo, M.C., Chen, H.C., et al. HCV infection complicated with nephrotic syndrome, immune complex crescentic glomerulonephritis and acute renal failure: a case report. Kaohsiung J Med Sci 21 (2005), 470–474.
25. Stokes, M.B., Chawla, H., Brody, R.I., et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 29 (1997), 514–525.
26. Haas, M., Kaul, S., Eustace, J.A., HIV-associated immune complex glomerulonephritis with “lupus-like” features: a clinicopathologic study of 14 cases. Kidney Int 67 (2005), 1381–1390.
27. Lloyd, W., Schur, P.H., Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) 60 (1981), 208–217.
28. Swaak, A.J., Groenwold, J., Bronsveld, W., Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 45 (1986), 359–366.
29. Sag, E., Tartaglione, A., Batu, E.D., et al. Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. Clin Exp Rheumatol 32 (2014), 440–444.
30. Fonseca, A.R., Gaspar-Elsas, M.I., Land, M.G., de Oliveira, S.K., Comparison between three systems of classification criteria in juvenile systemic lupus erythematous. Rheumatology (Oxford) 54 (2015), 241–247.
31. Ighe, A., Dahlstrom, O., Skogh, T., Sjowall, C., Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register. Arthritis Res Ther, 17, 2015, 3.
32. Lythgoe, H., Morgan, T., Heaf, E., et al. Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. Lupus, 2017 961203317700484.
33. Ungprasert, P., Sagar, V., Crowson, C.S., et al. Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria. Lupus 26 (2017), 240–247.
34. Pencina, M.J., D'Agostino, R.B. Sr., D'Agostino, R.B. Jr., Vasan, R.S., Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27 (2008), 157–172 discussion 207–212.